In early-stage lung adenocarcinoma (stage IA), 18F-FAPI-04 PET/CT demonstrated higher SUVmax and tumor-to-background ratios than FDG, with tracer uptake correlating with FAP expression on immunohistochemistry [171]. The gene discussed is FAP; the disease is lung adenocarcinoma.